NanJing Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
NanJing Pharmaceutical has a total shareholder equity of CN¥7.5B and total debt of CN¥10.3B, which brings its debt-to-equity ratio to 138.6%. Its total assets and total liabilities are CN¥32.6B and CN¥25.1B respectively. NanJing Pharmaceutical's EBIT is CN¥1.6B making its interest coverage ratio 4.3. It has cash and short-term investments of CN¥1.6B.
Key information
138.6%
Debt to equity ratio
CN¥10.34b
Debt
Interest coverage ratio | 4.3x |
Cash | CN¥1.64b |
Equity | CN¥7.46b |
Total liabilities | CN¥25.11b |
Total assets | CN¥32.56b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600713's short term assets (CN¥29.9B) exceed its short term liabilities (CN¥21.2B).
Long Term Liabilities: 600713's short term assets (CN¥29.9B) exceed its long term liabilities (CN¥3.9B).
Debt to Equity History and Analysis
Debt Level: 600713's net debt to equity ratio (116.7%) is considered high.
Reducing Debt: 600713's debt to equity ratio has reduced from 165.5% to 138.6% over the past 5 years.
Debt Coverage: 600713's debt is not well covered by operating cash flow (14.2%).
Interest Coverage: 600713's interest payments on its debt are well covered by EBIT (4.3x coverage).